Politics[Japan’s First] New Alzheimer’s Disease Drug “Lecanemab” Approved, Eliminates Causative Substance, First in Japan
On August 21, an expert panel of the Ministry of Health, Labor, and Welfare (MHLW) approved the manufacturing and market...
Worries about working at a foreign-affiliated company or changing jobs